Your browser doesn't support javascript.
loading
Etoricoxib-induced toxic epidermal necrolysis: A fatal case report.
Roy, Sukalyan Saha; Mukherjee, Shatavisa; Era, Nikhil; Mukherjee, Mala.
Afiliação
  • Roy SS; Department of Clinical and Experimental Pharmacology, Calcutta School of Tropical Medicine, Kolkata, West Bengal, India.
  • Mukherjee S; Department of Clinical and Experimental Pharmacology, Calcutta School of Tropical Medicine, Kolkata, West Bengal, India.
  • Era N; Department of Clinical and Experimental Pharmacology, Calcutta School of Tropical Medicine, Kolkata, West Bengal, India.
  • Mukherjee M; Department of Pathology, MGM Medical College, Kishanganj, Bihar, India.
Indian J Pharmacol ; 50(3): 139-142, 2018.
Article em En | MEDLINE | ID: mdl-30166751
Cyclooxygenase inhibitors were developed in the quest of enhanced analgesic efficacy devoid of gastric side effects. High usage of etoricoxib by prescription as well as self-administered routes has led to increasing reports of side effects and adverse reactions including dermatologic reactions in 0.1%-0.3% of cases. The present report enumerates a case of toxic epidermal necrolysis induced by etoricoxib.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Stevens-Johnson / Inibidores de Ciclo-Oxigenase 2 / Etoricoxib Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Stevens-Johnson / Inibidores de Ciclo-Oxigenase 2 / Etoricoxib Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article